Meta-Analysis
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2014; 20(18): 5548-5556
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5548
Table 3 Pooled effects of efficacy and safety in randomized controlled trials n (%)
ItemsIncidence of
Number of subjectsHetero-geneity I2 (P)Analysis modelTest for overall effect
RR/Peto OR (95%CI)
EPLBDESTZP value
(n = 303)(n = 318)
Complete stone removal rate93.7 (284)92.5 (294)6210% (0.82)Fixed0.610.54RR = 1.01
(M-H)(0.97-1.06)
Complete ductal clearance in one session82.2 (249)77.7 (247)62144% (0.13)Fixed1.360.17RR = 1.06
(M-H)(0.98-1.14)
Requirement for EML15.5 (47)25.2 (80)62110% (0.35)Fixed2.98  0.003aRR = 0.62
(M-H)(0.45-0.85)
Overall Adverse events7.9 (24)10.7 (34)6210% (0.97)Fixed1.160.25RR = 0.75
(M-H)(0.46-1.22)
Post-ERCP pancreatitis4.0 (12)5.0 (16)6210% (0.98)Peto0.620.54Peto OR = 0.79
(0.37-1.68)
Hemorrhage1.7 (5)2.8 (9)62128% (0.25)Peto1.000.32Peto OR = 0.57
(0.19-1.71)
Perforation0.3 (1)0.9 (3)62134% (0.22)Peto0.930.35Peto OR = 0.39
(0.06-2.81)
Acute cholangitis1.3 (4)1.3 (4)6210% (0.71)Peto0.110.92Peto OR = 1.08
(0.27-4.37)